|
By
Marilyn Mullen
|
|
Friday, 27 March 2015 13:49 |
 Orexigen Therapeutics, Inc. (NASDAQ:OREX) has confirmed that its weight-loss drug Mysimba has been approved by European Commission which can be used with a low-calorie diet as well as increased physical activity for patients who want lose weight.
|
|
Read more...
|
|
By
William Kent
|
|
Thursday, 26 March 2015 15:27 |
 Shares of Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) jumped 8% to $3.03 on moderate volume on Thursday after the company announced the new patent.
|
|
Read more...
|
|
By
Josh Gee
|
|
Wednesday, 25 March 2015 14:29 |
|
Avalanche Biotechnologies Inc. (NASDAQ:AAVL) shares slid 4% despite the company has announced that it has entered into an exclusive license agreement with University of Washington in Seattle for developing products based on Avalanche's proprietary Ocular BioFactory" Platform.
|
|
Read more...
|
|
By
Josh Gee
|
|
Monday, 23 March 2015 13:53 |
 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s shares fell 5.81 (-4.44%) to $125.19 after the company reported data of a 12-week Phase 2 study studying VX-661.
|
|
Read more...
|
|
By
William Kent
|
|
Friday, 20 March 2015 17:22 |
|
Biogen Idec Inc. (NASDAQ:BIIB) shares surged by 10.8% in morning session briefly due to high volume after giving an update about its keenly tracked Alzheimer's disease drug candidate aducanumab.
|
|
Read more...
|
|
By
William Kent
|
|
Friday, 13 March 2015 15:42 |
|
Organovo Holdings Inc (NYSEMKT:ONVO)’s shares climbed up 4% to $4.60 following the company updated about its business.
|
|
Read more...
|
|
By
Marilyn Mullen
|
|
Thursday, 12 March 2015 13:33 |
|
Shares of ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD) tumbled 21% in Thursday’s session on hefty volume after the company surprised its shareholders by announcing that it will delay the New Drug Application for its experimental Parkinson's disease psychosis drug nuplazid (pimavanserin) from this quarter to sometime in the 2nd half of the year.
|
|
Read more...
|
|
By
Marilyn Mullen
|
|
Tuesday, 24 February 2015 11:14 |
 Shares of Second Sight Medical Products Inc. (NASDAQ:EYES) soared 17% to $9.92 on hefty volume in early session on Tuesday.
|
|
Read more...
|
|
By
David Fowler
|
|
Monday, 23 February 2015 11:57 |
|
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) jumped as much as 39% to $3.53 in Monday’s session on hefty volume of 8.80 million shares 28X its average volume.
|
|
Read more...
|
|
By
Marilyn Mullen
|
|
Friday, 20 February 2015 14:52 |
 Shares of thinly-traded nano cap Celsion Corporation (NASDAQ:CLSN) jumped almost 13% to $3.16 on heavy volume in response to its update on its advancement of GEN-1, its DNA-based immunotherapy, for the front-line treatment of advanced platinum-resistant and recurring ovarian cancer.
|
|
Read more...
|
